Thread by @NatureCancer

🎉CELEBRATION ALERT!! We reached 10K followers @NatureCancer - massive thank you to our wonderful community for the warm welcome! Given it is also 10 months of our online life, here are some of our best articles (although all are *fantastic*) #thread 1/n

#10atNatureCancer

January @NatureCancer: Nabel &co @SanofiUS develp #trispecific antibodies against CD3, CD28 and CD38, with preclinical efficacy and safety in humanized mice and NHPs 2/n

go.nature.com/30GlQyH
rdcu.be/b78Zr

#10atNatureCancer

February @NatureCancer: Golub and Co @broadinstitute develop PRISM, a tool for non-oncology drug repurposing in #cancer 3/n

go.nature.com/36zCxQh
rdcu.be/b78ZE

#10atNatureCancer

March @NatureCancer: Ton Schumacher @NKI_nl and @BoussoLab show bystander IFN activity of tumor cells, with impact on #tumorimmunology 4/n

go.nature.com/3jEcfzT
rdcu.be/b7807

go.nature.com/3ljjBsX
rdcu.be/b781b

#10atNatureCancer

April @NatureCancer: A team led by @mmarra0630 &Co published the POG570 cohort of #clinical #genomic correlates to therapy in advanced tumors (check the Wikipedia for more info!) 5/n

go.nature.com/2Sul8QL
rdcu.be/b781m
bit.ly/36D16M7

#10atNatureCancer

May @NatureCancer: Chen &Co @Penn demonstrate that c-Rel is a myeloid checkpoint for #cancer #immunotherapy 6/n

go.nature.com/34pY1MI
rdcu.be/b783X

#10atNatureCancer

June @NatureCancer: @LabWendel &Co showed that altered Serine #metabolism through SHMT2 amplification cooperates with BCL2 in #DLBCl lymphomagenesis 7/n

go.nature.com/34ye7Um
rdcu.be/b784L

#10atNatureCancer

July @NatureCancer: Ira Mellman &Co @genentech demonstrated that PD-L1 expression by #DendriticCells is a key regulator of anti-cancer T-cell #Immunity 8/n

go.nature.com/3liQnuj
rdcu.be/b785h

#10atNatureCancer

August @NatureCancer: 2 studies by @jnkath & @MoritzGerstung show pan-cancer #computational histopathology to infer molecular features and more:

go.nature.com/2GpoEJQ
rdcu.be/b785B

go.nature.com/3d6exFK
rdcu.be/b785G

#AI #10atNatureCancer

September @NatureCancer: A #ClinicalTrial by @lillian_siu
and @PughLab demonstrate the utility of ctDNA #liquidbiopsy to predict #immunotherapy responses in solid tumors 10/n

go.nature.com/33CamhD
rdcu.be/b785B

#10atNatureCancerature

October @NatureCancer: a study led by @barlesi @AlbigesL &co provide insights into the #clinical correlates to worse #COVID19 outcomes in patients with cancer from the @GustaveRoussy cohort 11/n

go.nature.com/33y6BcZ
rdcu.be/b787w

#10atNatureCancer

So this was just a sample of our broad scope @NatureCancer but of course there is much wonderful content - check our website and stay alert for our exciting upcoming research. Thanks to all our authors, referees, readers - you are all stars! 12/end

#10atNatureCancer